ATHA: Athira Pharma, Inc. Stock

by  •  • Comments Off on ATHA: Athira Pharma, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 80.87
Enterprise Value ($M) -9.71
Book Value ($M) 130.19
Book Value / Share 3.40
Price / Book 0.62
NCAV ($M) 124.67
NCAV / Share 3.25
Price / NCAV 0.65

Profitability (mra)
Return on Invested Capital (ROIC) -0.89
Return on Assets (ROA) -0.51
Return on Equity (ROE) -0.56

Liquidity (mrq)
Quick Ratio 5.37
Current Ratio 5.37

Balance Sheet (mrq) ($M)
Current Assets 154.73
Assets 160.25
Liabilities 30.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -127.09
Net Income -117.67

Cash Flow Statement (mra) ($M)
Cash From Operations -100.75
Cash from Investing 95.09
Cash from Financing 0.49

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Baker Bros. Advisors Lp 8.30
12-29 13D/A Perceptive Advisors Llc 14.30 13.45
07-07 13G/A BlackRock Inc. 1.80 -71.66
04-20 13G Kayne Richard A 5.30

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 42,618 194,132 21.95
2024-04-17 29,985 110,468 27.14
2024-04-16 8,963 45,780 19.58
2024-04-15 62,490 74,567 83.80

(click for more detail)

Similar Companies
ARVN – Arvinas, Inc. ARWR – Arrowhead Pharmaceuticals, Inc.
ASMB – Assembly Biosciences, Inc. ATRA – Atara Biotherapeutics, Inc.
AVIR – Atea Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io